Cardiothoracic & vascular anesthesia

Efficacy of Perioperative Infusion of N(2)-L-alanyl-L-glutamine in Glycemic Control for Patients With Uncontrolled Diabetes Mellitus Presented for Urgent Coronary Artery Bypass Surgery: A Randomized Controlled Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

A preoperative infusion of dipeptiven can contribute to ameliorating stress hyperglycemia in uncontrolled diabetic patients undergoing urgent CABG.

Study context

Population
Patients with uncontrolled type 2 DM (HbA1c >7%) undergoing urgent coronary artery bypass graft (CABG)
Participants
93 patients
Comparison
Preoperative dipeptiven infusion vs normal saline
  • Dipeptivenn = 46
  • Controln = 47reference
Methodological detailssingle-centre, Ain Shams University Hospital, Cardiothoracic Academy
  • Single-centre
  • Ain Shams University Hospital, Cardiothoracic Academy

Primary result

As reported in the abstract

Mean total insulin requirements · Intraoperative and postoperative

Dipeptiven reduced mean total insulin requirements intraoperatively by (vs placebo)

3.64 ± 0.56 units/h

Dipeptiven reduced mean total insulin requirements postoperatively by (vs placebo)

37.109 ± 4.30 units/24 h

Further findings

Mean blood glucose, intraoperative

Mean blood glucose, postoperative

Mean blood glucose, intraoperative

Statistically significantly lower in the Dipeptiven group

Mean blood glucose, postoperative

Statistically significantly lower in the Dipeptiven group

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Efficacy of Perioperative Infusion of N(2)-L-alanyl-L-glutamine in Glycemic Control for Patients With Uncontrolled Diabetes Mellitus Presented for Urgent Coronary Artery Bypass Surgery: A Randomized Controlled Trial. J Cardiothorac Vasc Anesth. Published 9 July 2023. doi:10.1053/j.jvca.2023.07.004

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.